Cyclodextrins in doll-inspired nanostructures for cancer therapy
A young researcher working at the Centre de Recherche en Automatique de Nancy, Centre National de la Recherche Scientifique has recently
Category: Uncategorized
Amgen’s Kyprolis, J&J’s Darzalex team up on myeloma survival win
After years of slow growth, Amgen’s Kyprolis finally looks poised to break the blockbuster barrier in 2019, and new data
New real-world data support long-term efficacy and safety profile of MAVENCLAD
Merck, a leading science and technology company, announced the presentation of new data for MAVENCLAD® (cladribine tablets), which further characterise
Cyclodextrin-based nanozymes
Nanozymes are nanomaterials with enzyme-like properties. These artificial enzymes have emerged more robust than the natural enzymes and find applications
Pharma-Congress – 2019
The conference on “Pharmaceutical Drug Research and Industry Field Innovations” is scheduled to be held on November 25-26, 2019 Singapore. The theme
HPBCD is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease
Niemann-Pick type C1 (NPC1) disease is a fatal neurovisceral disease for which there are no FDA approved treatments, though cyclodextrin
Fraud companies infiltrating cyclodextrin business
I would like to draw your attention to a very recent desperate approach for taking advantage of one’s naivety and